Norwegian (OSEAX) Healthcare Sector Analysis
UpdatedMay 19, 2024
DataAggregated Company Financials
Companies25
- 7D2.7%
- 3M-24.9%
- 1Y-45.2%
- YTD-31.3%
In the last week, the Healthcare industry is up 2.7%, with Nordhealth up 15%. During this same period, the Vistin Pharma underperformed, falling 6.8%. However, the industry is down 45% over the past year. Looking forward, earnings are forecast to grow by 28% annually.
Sector Valuation and Performance
Has the Norwegian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 19 May 2024 | kr22.1b | kr4.2b | -kr1,170,293,200.33 | 17.3x | -18.9x | 5.2x |
| Tue, 16 Apr 2024 | kr21.7b | kr4.2b | -kr1,121,044,469.34 | 27.5x | -19.4x | 5.2x |
| Thu, 14 Mar 2024 | kr21.6b | kr4.2b | -kr1,077,566,591.81 | 28x | -20.1x | 5.2x |
| Sat, 10 Feb 2024 | kr28.6b | kr4.1b | -kr1,279,053,108.42 | 24x | -22.3x | 7x |
| Mon, 08 Jan 2024 | kr30.5b | kr4.1b | -kr1,580,498,713.00 | 23.4x | -19.3x | 7.5x |
| Wed, 06 Dec 2023 | kr27.8b | kr4.1b | -kr1,597,424,828.00 | 21.8x | -17.4x | 6.8x |
| Fri, 03 Nov 2023 | kr26.2b | kr3.5b | -kr1,858,445,926.00 | 32.4x | -14.1x | 7.5x |
| Sun, 01 Oct 2023 | kr28.1b | kr3.5b | -kr1,792,551,596.00 | 33.7x | -15.7x | 7.9x |
| Tue, 29 Aug 2023 | kr28.1b | kr3.6b | -kr1,804,798,542.00 | 31.8x | -15.6x | 7.8x |
| Thu, 27 Jul 2023 | kr29.6b | kr3.4b | -kr1,817,153,978.00 | 29.6x | -16.3x | 8.8x |
| Sat, 24 Jun 2023 | kr28.9b | kr3.4b | -kr1,805,323,388.00 | 42.2x | -16x | 8.5x |
| Mon, 22 May 2023 | kr30.4b | kr3.4b | -kr1,820,281,960.00 | 46x | -16.7x | 9x |
| Wed, 19 Apr 2023 | kr30.3b | kr3.1b | -kr1,784,548,083.00 | 31.8x | -17x | 9.7x |
| Fri, 17 Mar 2023 | kr28.2b | kr3.1b | -kr1,882,755,106.00 | 30.1x | -15x | 9.1x |
| Sun, 12 Feb 2023 | kr33.6b | kr3.6b | -kr1,856,338,694.00 | 35.3x | -18.1x | 9.3x |
| Tue, 10 Jan 2023 | kr33.4b | kr3.6b | -kr1,833,423,430.00 | 35.3x | -18.2x | 9.3x |
| Thu, 08 Dec 2022 | kr33.0b | kr3.6b | -kr1,835,544,901.00 | 36.8x | -18x | 9.2x |
| Sat, 05 Nov 2022 | kr32.5b | kr3.5b | -kr1,746,574,637.00 | 39.3x | -18.6x | 9.2x |
| Mon, 03 Oct 2022 | kr30.2b | kr3.5b | -kr1,780,142,382.00 | 55.8x | -17x | 8.7x |
| Wed, 31 Aug 2022 | kr36.2b | kr3.4b | -kr1,769,216,063.00 | 59.4x | -20.5x | 10.6x |
| Fri, 29 Jul 2022 | kr36.5b | kr3.3b | -kr1,741,780,105.00 | 84.2x | -20.9x | 11.1x |
| Sun, 26 Jun 2022 | kr36.5b | kr3.3b | -kr1,702,991,283.00 | 49.9x | -21.4x | 11x |
| Tue, 24 May 2022 | kr38.0b | kr3.6b | -kr1,322,604,904.00 | 48.5x | -28.7x | 10.5x |
| Thu, 21 Apr 2022 | kr42.9b | kr3.4b | -kr1,202,109,665.00 | 43.9x | -35.7x | 12.4x |
| Sat, 19 Mar 2022 | kr43.3b | kr5.1b | kr176.3m | 38.6x | 245.4x | 8.5x |
| Mon, 14 Feb 2022 | kr49.0b | kr5.0b | kr312.9m | 59.7x | 156.7x | 9.9x |
| Wed, 12 Jan 2022 | kr60.3b | kr4.4b | -kr123,996,797.00 | 60.1x | -486.4x | 13.6x |
| Fri, 10 Dec 2021 | kr61.0b | kr4.5b | -kr76,907,886.00 | 68x | -793.3x | 13.6x |
| Sun, 07 Nov 2021 | kr61.2b | kr4.7b | kr370.2m | 48.1x | 165.3x | 13x |
| Tue, 05 Oct 2021 | kr60.9b | kr4.6b | kr382.7m | 64.9x | 159x | 13.1x |
| Thu, 02 Sep 2021 | kr64.9b | kr4.6b | kr425.6m | 66x | 152.4x | 14x |
| Sat, 31 Jul 2021 | kr58.8b | kr4.6b | kr425.6m | 68.4x | 138.2x | 12.7x |
Price to Earnings Ratio
141.6x
Current Industry PE
- Investors are pessimistic on the Norwegian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 9.8x is higher than the industry's current PS ratio of 5.2x.
Past Earnings Growth
- Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have remained mostly flat.
- This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Norwegian Healthcare sector?
| NO Market | -1.02% | |
| Healthcare | 2.71% | |
| Healthtech | 6.37% | |
| Healthcare Services | 2.72% | |
| Medical Equipment | 2.36% | |
| Biotech | 1.78% | |
| Life Sciences | 0% | |
| Pharma | -0.0086% | |
Industry PE
- Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 74.0%, which is lower than the prior year's growth of 654.9% per year.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 74% over the next 5 years.
- However this is lower than its past earnings growth rate of 655% per year.
- In contrast, the Biotech industry is expected to see its earnings decline by 11% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NORDH Nordhealth | kr34.60 | 15.0% +kr355.7m | 74.7% | PS6.1x | |
| NYKD Nykode Therapeutics | kr14.67 | 4.5% +kr205.7m | -44.0% | PS40.7x | |
| LIFE Lifecare | kr3.10 | 17.0% +kr60.7m | 65.5% | PS38.3x | |
| PHO Photocure | kr60.00 | 3.8% +kr59.6m | 12.1% | PE337.3x | |
| MEDI Medistim | kr179.00 | 1.7% +kr54.9m | -38.7% | PE32x |